Evidence map›Paper›PMID 36406236›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Ting Tang, Qiang Zhu, Shuang Liu, Hailong Dai, Yu Li, Caihong Tang, Kexin Chen, Mou Jiang, Lijun Zhu, Xin Zhou and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Perfluorocarbon-Loaded Poly(lactide-ACS applied polymer materials · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Ting TangHunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Department of Pharmacy, Hengyang Medicinal School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Qiang ZhuHunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Department of Pharmacy, Hengyang Medicinal School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Shuang LiuDepartment of Pediatrics, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
Hailong DaiHunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Department of Pharmacy, Hengyang Medicinal School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Yu LiState Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, China.
Caihong TangHunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Department of Pharmacy, Hengyang Medicinal School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Kexin ChenHunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Department of Pharmacy, Hengyang Medicinal School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Mou JiangState Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, China.
Lijun ZhuState Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, China.
Xin ZhouState Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, China.
ShiZhen ChenState Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, China.
Zitong ZhengHunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Department of Pharmacy, Hengyang Medicinal School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Zhong-Xing JiangState Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, China.
Chinese Academy of Sciences · CNUniversity of South China · CNWuhan Institute of Physics and Mathematics · CNChangchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a noninvasive "hot-spot" imaging technology, fluorine-19 magnetic resonance imaging (

Indexed as

19F MRIcell trackingfluorescencenanoemulsionspartially fluorinated

Identifiers

PMID36406236
PMCPMC9669590
OpenAlexW4308415185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.